Your session is about to expire
← Back to Search
Dextromethorphan + Fluoxetine for Obsessive-Compulsive Disorder
Study Summary
This trial will study whether a combination of dextromethorphan and fluoxetine is effective and tolerable in treating symptoms of OCD and related disorders.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 43 Patients • NCT00245635Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with OCD, BDD, IAD, or SSD.I have been diagnosed with OCD, BDD, IAD, or SSD.I have bipolar or psychotic disorder.I understand and can agree to the study's procedures and risks.I have not taken any mental health medications except fluoxetine in the last 2 weeks.I started OCD therapy focusing on exposure and response prevention within the last 2 months.
- Group 1: Group B: fluoxetine plus dextromethorphan then fluoxetine
- Group 2: Group A: fluoxetine then fluoxetine plus dextromethorphan
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What adverse effects should be monitored when using Fluoxetine?
"Our internal assessment at Power has concluded that Fluoxetine is relatively safe, scoring a 2 out of 3 due to the fact its safety profile has been demonstrated in Phase 2 trials without any certainty surrounding efficacy."
Is the enrollment period still open for this investigation?
"As per clinicaltrials.gov, this research is actively recruiting participants. The trial posting was first launched on January 20th 2022 and recently modified on March 15th 2022."
Does the study include adults over a quarter-century of age?
"Patients aged between 18 and 65 are suitable for this trial. Subsequently, there are 342 trials that accept minors and 884 entries available to those over the age of retirement."
How many individuals have been recruited to participate in this trial?
"That is correct. According to the data posted on clinicaltrials.gov, this medical study began recruiting patients in January of 2022 and was last updated in March that same year. Overall recruitment goals are set at 60 individuals being enrolled from one location."
Does my profile meet the criteria to partake in this experiment?
"This clinical trial has a strict eligibility criteria. To be considered, individuals must have body dysmorphic disorder and not exceed the age of 65 nor fall below 18 years old. Additionally, 60 patients are required for this study to proceed."
What disorders or conditions is Fluoxetine regularly prescribed for?
"Fluoxetine is often prescribed to treat unipolar depression, as well as ocular ailments and sinus-related issues such as rhinorrhoea."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger